Manufacturing Delay10 May 2019 08:41
Now this RNS has shown that problem is now "SORTED" ... so this super high Tech vaccine of hydrophobic peptides combined with a linked adjuvant will be available later this year ..
and the full weight of Lindy Durrants Peers are stepping up to support and advise on what could be a £3 billion research project ...
resulting in more than 34 major cancer trials involving mono, combo, and TCR vaccination strategies based around the Vimentin expression cancers
so exciting